Detalhe da pesquisa
1.
Effects of tyrosine kinase inhibitors on androgen, estrogen α, glucocorticoid and thyroid receptors.
Toxicol Appl Pharmacol
; 434: 115818, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890638
2.
The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies.
Int J Mol Sci
; 23(3)2022 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163524
3.
Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax.
Cell Death Dis
; 13(10): 860, 2022 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209148
4.
Targeting Autophagy Triggers Apoptosis and Complements the Action of Venetoclax in Chronic Lymphocytic Leukemia Cells.
Cancers (Basel)
; 13(18)2021 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572784
5.
EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells.
Biochem Pharmacol
; 183: 114352, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278351
6.
A Putative Serine Protease is Required to Initiate the RIPK3-MLKL-Mediated Necroptotic Death Pathway in Neutrophils.
Front Pharmacol
; 11: 614928, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33551816